|
BD-2 selective bromodomain inhibitors
|
6
|
Resverlogix Corp.
|
Sep 15, 2018 10:58AM
|
|
Re: The 3 inflection points: SSRA, Top-Line, Full Data
|
4
|
Resverlogix Corp.
|
Sep 15, 2018 12:05PM
|
|
Re: I'm glad the SSRA issue has finally been put to bed....
|
7
|
Resverlogix Corp.
|
Sep 18, 2018 05:54PM
|
|
RVX AGM Q&A, post AGM-huddle, impressions
|
5
|
Resverlogix Corp.
|
Sep 18, 2018 08:29PM
|
|
Re: I'm glad the SSRA issue has finally been put to bed....
|
2
|
Resverlogix Corp.
|
Sep 18, 2018 09:48PM
|
|
FXR and liver transaminase related adverse events
|
7
|
Resverlogix Corp.
|
Sep 18, 2018 11:25PM
|
|
Re: FXR and liver transaminase related adverse events
|
4
|
Resverlogix Corp.
|
Sep 19, 2018 06:58AM
|
|
Re: I'm glad the SSRA issue has finally been put to bed....
|
5
|
Resverlogix Corp.
|
Sep 19, 2018 07:04AM
|
|
Re: Saw these articles that might be relevant to us,...
|
6
|
Resverlogix Corp.
|
Sep 20, 2018 07:15PM
|
|
Re: Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study (BRD4i)
|
5
|
Resverlogix Corp.
|
Sep 21, 2018 10:53AM
|
|
Re: Looking at the chart...introducing the bullish channel
|
7
|
Resverlogix Corp.
|
Sep 21, 2018 06:00PM
|
|
Re: NIH Halts Large Cardiovascular Inflammation Reduction Trial (CIRT)
|
6
|
Resverlogix Corp.
|
Sep 22, 2018 10:58AM
|
|
Re: Resverlogix H2 2018 events
|
6
|
Resverlogix Corp.
|
Sep 22, 2018 05:58PM
|
|
Re: NIH Halts Large Cardiovascular Inflammation Reduction Trial (CIRT)
|
4
|
Resverlogix Corp.
|
Sep 23, 2018 07:58AM
|
|
Re: NIH Halts Large Cardiovascular Inflammation Reduction Trial (CIRT)
|
5
|
Resverlogix Corp.
|
Sep 23, 2018 01:42PM
|
|
REDUCE-IT CVOT Meets Primary Endpoint
|
6
|
Resverlogix Corp.
|
Sep 24, 2018 10:01AM
|
|
Re: REDUCE-IT CVOT Meets Primary Endpoint
|
5
|
Resverlogix Corp.
|
Sep 24, 2018 12:09PM
|
|
Re: REDUCE-IT CVOT Meets Primary Endpoint
|
5
|
Resverlogix Corp.
|
Sep 24, 2018 12:22PM
|
|
Re: NIH Halts Large Cardiovascular Inflammation Reduction Trial (CIRT)
|
5
|
Resverlogix Corp.
|
Sep 24, 2018 03:23PM
|
|
Re: NIH Halts Large Cardiovascular Inflammation Reduction Trial (CIRT)
|
5
|
Resverlogix Corp.
|
Sep 25, 2018 12:35PM
|
